No Detail Found!

Can Next-generation Sequencing Replace Fecal Immunochemical Tests or CT in the Screening of Colorectal Cancer and Advanced Adenoma?

Author(s)
Xiaoling Ye Department of Gastroenterology, Renmin Hospital of Wuhan University,ChinaGastroenterology, Renmin Hospital of Wuhan University,China
Hong Chai Department of Gastroenterology, Renmin Hospital of Wuhan University,ChinaGastroenterology, Renmin Hospital of Wuhan University,China
Chunyan Huang Department of Gastroenterology, Renmin Hospital of Wuhan University,ChinaGastroenterology, Renmin Hospital of Wuhan University,China
Miao Liu Department of Gastroenterology, Renmin Hospital of Wuhan University,ChinaGastroenterology, Renmin Hospital of Wuhan University,China
Tao Deng Department of Gastroenterology, Renmin Hospital of Wuhan University,ChinaGastroenterology, Renmin Hospital of Wuhan University,China
Abstract
Objective: To explore the feasibility of next-generation sequencing (NGS) for the screening of colorectal cancer (CRC) and advanced adenoma (AA). Study Design: Observational study. Place and Duration of the Study: Renmin Hospital of Wuhan University, Wuhan, China, from June 2019 to February 2020. Methodology: Patients who met inclusion and exclusion criteria were divided into three groups: CRC, AA, and control group. Then, the gene methylation status in the blood in the CRC, AA, and control group was analysed by NGS, and the CRC screening risk assessment model was used for comprehensive analysis. Afterwards, the methylated haplotype index (PHF Index) was calculated, and the screening results of the patients were classi ed as positive or negative, according to the score. The clinicopathological results were used as the gold standard, and the screening results for NGS were compared with the computed tomography (CT) and fecal immunochemical test (FIT) to text its feasibility. Results: NGS has a certain detection ability for CRC, with a sensitivity of 57.1% (8/14). This was higher than that of FIT and CT, and the combined positive rate of these three methods could reach 92.3% (12/13). The sensitivity of detection of AA could reach up to 75.0% (6/8) after combining with FIT and CT. The positive rate of the NGS test for postoperative CRC was 23.1% (3/13), which was signi cantly lower than preoperative CRC. The sensitivity of CT for preoperative CRC detection was only 45.5% (5/11), but the speci city could reach up to 98.2% (55/56), which was higher than NGS (71/78, 91.0%) and FIT (27/33, 81.8%). Conclusion: Although NGS cannot replace FIT and CT at present, this provides a new e ective and auxiliary detection method for people who are unsuitable or unwilling to receive colonoscopy.
Publication Details
Page(s) 940-945
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 30, Issue: 9, Year: 2020

Request the full text from PASTIC

Keywords
Computed tomography, Adenoma, Colorectal neoplasms, Fecal immunochemical tests, Mass screening, High-throughput nucleotide sequencing
0

Citations

0

Downloads

83

Views